At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
Chokeberry Extract +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Chokeberry Polyphenols on Biomarkers of Cardiovascular Disease and Antioxidant Defenses in Former Smokers
In Brief
A clinical study evaluating Chokeberry Extract, Placebo capsule, and 1 other intervention for Cardiovascular Disease and Oxidative Stress. Completed, enrolled 62 participants across 1 site.
Detailed Summary
The purpose of this project is to determine whether chokeberry polyphenols mitigate cardiovascular disease risk in former smokers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease, Oxidative Stress
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
First PostedMar 2012
Primary CompletionAug 2015
Study CompletionDec 2016
TodayJul 2026
First PostedMar 1, 2012
Enrollment StartFeb 1, 2012
Primary CompletionAug 1, 2015
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 14.3 years ago
Interventions
Chokeberry Extractdietary
Consumption of 2 x 250 mg chokeberry extract capsules daily for 12 weeks.
Placebo capsuledietary
Color-matched rice powder pill, 2 x 250 mg/day for 12 weeks
Chokeberry extract capsule, acutedietary
Chokeberry extract capsule, 2 x 250 mg, one-time dose.